Revelation Biosciences Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.
The company stated in the following report that they exploit animals for drug testing.
“An in vivo (in animals), placebo controlled preclinical study using early IFN–β treatment and showed increase in survival and a reduction in cytokine storm in mice. In this study, mice challenged with the SARS-CoV-2 virus were administered intranasal IFNβ either 6, 12 or 24 hours post infection with SARS-CoV-2 and showed increased survival rate vs placebo (PBS) when treated early (Cell Host & Microbe 19, 181 – 193, February 10, 2016).” (Page 71) Read the full document
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis. The company was founded in 2020 and is based in San Diego, California.
Company Website: https://www.revbiosciences.com